Involvement of Histidine Residue His382 in pH Regulation of MCT4 Activity

Shotaro Sasaki; Masaki Kobayashi; Yuya Futagi; Jiro Ogura; Hiroaki Yamaguchi; Ken Iseki

doi:10.1371/journal.pone.0122738

Abstract

Monocarboxylate transporter 4 (MCT4) is a pH-dependent bi-directional lactate transporter. Transport of lactate via MCT4 is increased by extracellular acidification. We investigated the critical histidine residue involved in pH regulation of MCT4 function. Transport of lactate via MCT4 was measured by using a Xenopus laevis oocyte expression system. MCT4-mediated lactate transport was inhibited by Zn²⁺ in a pH physiological condition but not in an acidic condition. The histidine modifier DEPC (diethyl pyrocarbonate) reduced MCT4 activity but did not completely inactivate MCT4. After treatment with DEPC, pH regulation of MCT4 function was completely knocked out. Inhibitory effects of DEPC were reversed by hydroxylamine and suppressed in the presence of excess lactate and Zn²⁺. Therefore, we performed an experiment in which the extracellular histidine residue was replaced with alanine. Consequently, the pH regulation of MCT4-H382A function was also knocked out. Our findings demonstrate that the histidine residue His382 in the extracellular loop of the transporter is essential for pH regulation of MCT4-mediated substrate transport activity.

Citation: Sasaki S, Kobayashi M, Futagi Y, Ogura J, Yamaguchi H, Iseki K (2015) Involvement of Histidine Residue His382 in pH Regulation of MCT4 Activity. PLoS ONE 10(4): e0122738. https://doi.org/10.1371/journal.pone.0122738

Academic Editor: Hernâni Gerós, University of Minho, PORTUGAL

Received: November 5, 2014; Accepted: February 12, 2015; Published: April 28, 2015

Copyright: © 2015 Sasaki et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

Data Availability: All relevant data are within the paper.

Funding: This work was funded in part by a grant from the Northern Advancement Center for Science and Technology and from the Grant-in-Aid for Young Scientists (B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Monocarboxylate transporter 4 (MCT4) is an H⁺ gradient-dependent lactate transporter [1]. The transporter is identical to solute carrier family 16, member 3 (SLC16A3), the function of which has been determined and which has been shown to have a low affinity for lactate compared to other lactate carriers [1–4].

It has been shown that critical functional positions within MCT4 include the amino acid residue involved in lactate recognition, but the detailed pH regulation mechanism has not yet been determined [1]. Previous reports for other H⁺/substrate co-transporters suggest important roles for histidine residues [5]. Natural resistance-associated macrophage protein 2 (Nramp2/SLC11A2) is a pH-dependent divalent metal transporter with broad substrate specificity including Fe²⁺, Mn²⁺, Co²⁺, Cd²⁺, Cu²⁺, Ni²⁺, Pb²⁺, and possibly Zn²⁺ and may function by an H⁺ cotransport mechanism [6]. His267/His272 are not directly involved in metal binding but, rather, play an important role in pH regulation of metal transport by Nramp proteins [7]. The human H⁺-coupled folate transporter PCFT (SLC46A1) is involved in the transport of folates across the apical membranes of enterocytes within the acidic microclimate at the absorptive surface of the proximal jejunum [8]. His281 is not essential for proton coupling to the carrier [9]. H⁺-coupled oligopeptide transporter PEPT1 was assigned to the solute carrier family 15 as SLC15A1 [10]. Transport activity of PEPT1 is inhibited by diethyl pyrocarbonate (DEPC), and His57 of PEPT1, located at or near the substrate binding site, is involved in the pH regulation of transport activity [11]. DEPC is known to suppress the H⁺ acceptor or donor function of histidine residues of proteins. The transport activity of human H⁺-coupled amino acid transporter PAT1 (SLC36A1) is also inhibited by DEPC, and it was shown that a histidine residue is important for the transport activity of PAT1 [12, 13].

MCT4 is composed of 465 amino acid residues and is predicted to contain 12 transmembrane domains. This transporter has five histidine residues, one in the extracellular loop, another in the intracellular loop and the other three in the carboxy terminal facing the cytosol [1]. The present study, using chemical modification by DEPC and site-directed mutagenesis, was carried out to confirm that histidine residues are involved in the pH regulation of MCT4 activity. There has been no mutational study of histidine residues in MCT4. Our investigation showed that His382 is essential for the regulation of pH-sensitive transport activity of the transporter.

Methods

Synthesis of cRNA

Molecular cloning of MCT4 and MCT1 was performed as previously described [1, 14]. Plasmids were linearized with NotI (MCT1) or XhoI (MCT4), and MCT1 and MCT4 cRNAs were synthesized in vitro using T7 RNA polymerase (Epicentre) from these cDNAs.

Site-directed mutagenesis

An MCT4 mutant was obtained by using the Quickchange protocol (Agilent). The mutagenic oligonucleotides used were 5’-GATGCGACCGCCGTCTACATGTACGTGTTC-3’ for the forward primer and 5’-CATGTAGACGGCGGTCGCATCCAGGAGTTTG-3’ for the reverse primer, which replace a histidine residue at position 382 with alanine (MCT4-H382A). A High Pure Plasmid Isolation Kit (Roche) was used to isolate the plasmid DNA. Mutation was confirmed by DNA sequencing using a BigDye Terminator v3.1 Cycle Sequencing Kit from Applied Biosystems.

Uptake measurements in MCT1 cRNA or MCT4 cRNA-injected oocytes

Xenopus laevis oocytes were collected under anesthesia (immersion in a solution of 1 g/l MS-222) from toads. Stage IV or V oocytes from Xenopus laevis were isolated and maintained at 17°C in Barth’s solution as previously described [1]. Oocytes were injected with 50 ng cRNA in a 50-nl volume and incubated for 3–6 days. The transport functions of heterologously expressed MCT1 and MCT4 were monitored. The transport buffer used in this study was a standard buffer (100 mM NaCl, 2 mM KCl, 1 mM MgCl₂, 1 mM CaCl₂, and 10 mM Good’s buffer). HEPES was used for pH 8.0–7.0 buffer, and MES was used for pH 7.0–5.5 buffer. We measured the uptake of radiolabeled compounds (L-lactate [¹⁴C: 0.1 μCi/ml], nicotinic acid [³H: 0.5 μCi/ml] and salicylic acid [¹⁴C: 0.1 μCi/ml]) by using a liquid scintillation counter. Uptake of a radiolabeled compound in water-injected and cRNA-injected oocytes was performed, and oocytes were washed with ice-cold transport buffer as previously described [1]. Metal inhibition of 0.1 mM lactate uptake by oocytes expressing MCT4-WT, MCT4-H382A and MCT1 and water-injected oocytes was measured in the presence or absence of 5 mM of each metal. The oocytes were incubated with metals and [¹⁴C] lactate for 10 min. We performed the experiments using DEPC and hydroxylamine in conformity to the method of Baird et al. [15]. All data are given as means±S.E. of three independent experiments, and 12–15 oocytes were used in each of the experiments on uptake of radiolabeled compounds. Student’s t test was used to determine the significance of differences between the means of two groups. Statistical significance among means of more than two groups was analyzed by one-way analysis of variance (ANOVA). p<0.05 was considered statistically significant.

Materials

[¹⁴C] L-lactate, [³H] nicotinic acid and [¹⁴C] salicylic acid were obtained from American Radiolabeled Chemicals. Xenopus laevis toads were obtained from Hokudo. Permission for this study was obtained from the Committee on Animal Experimentation, Hokkaido University. All other chemicals used were of the highest purity available.

Results

Effects of metals on transport activity of MCT4

We investigated the transport of lactate via MCT4 using a heterologous functional expression system. We expressed cloned MCT4 in Xenopus laevis oocytes by injection of cRNA. First, we examined that effect of 5 mM of each metal on MCT4-mediated transport of lactate at pH 7.5. The transport of lactate (0.1 mM) via MCT4 was markedly inhibited by the metals with inhibitory effects in the order of copper > nickel > zinc (Fig 1A). In contrast, MCT1-mediated lactate transport was not inhibited by the metals (p>0.05) (Fig 1B). We also investigated the inhibitory effect of zinc at pH 5.5 on the transport of lactate by MCT4. Under this condition, we could not detect interaction of zinc with MCT4 (p>0.05) (Fig 1A: inset). The metals combined with an amino acid residue(s), and the pK_a of this residue is between 5.5 and 7.5. This value accords with pK_a of the histidine residue having an imidazole group of its side chain. These results imply that the metals combined with a histidine residue of MCT4.

Download:

Fig 1. Inhibitory effects of metals on MCT4-mediated lactate uptake.

(A) MCT4-mediated uptake of 0.1 mM lactate (0.1 μCi/ml) was measured in a transport buffer of pH 7.5 containing 5 mM of each metal for 10 min. The inset shows the effect of 5 mM zinc under an acidic condition (pH 5.5). (B) MCT1-mediated uptake of 0.1 mM lactate (0.1 μCi/ml) was measured in a transport buffer of pH 7.5 containing 5 mM of each metal for 10 min. The background uptake values of water-injected oocytes were subtracted. Data are presented as means±S.E. of three experiments.

https://doi.org/10.1371/journal.pone.0122738.g001

Effect of a histidine residue modifier, DEPC, on lactate transport through MCT4-expressing oocytes

DEPC is considered to be specific for histidine within the pH range of 5.5–7.5 [16] as was used in this study. Lactate transport via MCT4 under the condition of DEPC treatment was decreased substantially but did not completely disappear (Fig 2A). The K_0.5 for inactivation of DEPC was approximately 1.5 mM for MCT4 with DEPC treatment time of 10 min. On the other hand, DEPC treatment completely abolished the transport activity of MCT1. As shown in Fig 2B, MCT4 clearly showed pH-sensitive transport activity that increased with increase in extracellular proton concentration, whereas the pH sensitivity of MCT4 was voided by exposure to DEPC. Additionally, we tested the effect of hydroxylamine to determine whether the effects of DEPC would be reversed. Treatment with 50 mM hydroxylamine for 1 h resulted in recovery from the inactivation of DEPC (Fig 3). DEPC and zinc also react with cysteine residues in a protein under certain conditions, though we previously reported that the cysteine-modifying agent 5,5’-dithio-bis(2-nitrobenzoic acid) (DTNB) has no effect on MCT4-mediated lactate transport [1]. These results indicated that the DEPC-modified histidine residue is an H⁺ binding site and extracellular pH sensor.

Download:

Fig 2. Inhibitory effects of DEPC on MCT4-mediated uptake of lactate.

(A) Oocytes expressing MCT4 and MCT1 were washed and incubated at 25°C with DEPC at different doses. After 10 min, the oocytes were washed twice and incubated with a transport buffer (pH 5.5) containing 0.1 mM lactate (0.1 μCi/ml) for 10 min. (B) Oocytes were subjected to a 10-min pre-incubation in a transport buffer (pH 7.5) containing 2.5 mM DEPC at 25°C. The oocytes were washed and uptake of 0.1 mM lactate (0.1 μCi/ml) was measured for 10 min at the pH values indicated. Values for water-injected oocytes were subtracted from the values for MCT4-expressing oocytes. Each value is the mean±S.E. of three experiments.

https://doi.org/10.1371/journal.pone.0122738.g002

Download:

Fig 3. Determination of the kind of DEPC-sensitive residue.

Oocytes were pre-incubated for 10 min in a transport buffer in the presence or absence of DEPC (2.5 mM). After DEPC treatment, the oocytes were additionally incubated for 1 h in a transport buffer in the presence or absence of hydroxylamine (50 mM). The oocytes were incubated for 10 min in a transport buffer of pH 5.5 containing 0.1 mM lactate (0.1 μCi/ml). Data are presented as means±S.E. of three experiments. MCT4-specific uptake was calculated by subtracting the uptake in water-injected oocytes from the uptake in MCT4 cRNA-injected oocytes.

https://doi.org/10.1371/journal.pone.0122738.g003

Effects of monocarboxylates on the DEPC modification of MCT4

Since the histidine residue might have been located in the proton binding site, we investigated the effects of monocarboxylates on the DEPC modification of MCT4. Fig 4 shows the effects of lactate, propionic acid, nicotinic acid, salicylic acid and ibuprofen on DEPC inactivation of lactate uptake via MCT4. It is known that lactate and nicotinic acid are taken up by MCT4. Additionally, propionic acid and ibuprofen possess the propionic acid structure as well as lactate. The structures of salicylic acid and nicotinic acid are also very similar. The inhibitory effect of DEPC on MCT4-mediated transport activity was prevented by lactate and nicotinic acid but not by propionic acid, salicylic acid or ibuprofen. These results indicated that nicotinic acid, but not salicylic acid, is a potential substrate of MCT4. To elucidate the binding site of zinc, we also investigated the effect of zinc on DEPC treatment of MCT4. The DEPC-induced suppression of lactate uptake via MCT4 was also prevented by zinc. This result indicated that lactate, nicotinic acid and zinc bind to the same histidine residue as that involved in regulation of pH-dependent activity by MCT4. We investigated the transport of nicotinic acid and salicylic acid, the structures of which are very similar, via MCT4 (Table 1). The uptake of nicotinic acid was greater in cRNA-injected oocytes than in water-injected oocytes. In contrast, cRNA-induced salicylic acid uptake activity was not detected. We next investigated the effect of extracellular pH on nicotinic acid transport via MCT4 (Fig 5A). The uptake of nicotinic acid by MCT4-expressing oocytes was reduced by alkalizing the extracellular pH, indicating that nicotinic acid uptake via MCT4 involves a proton-linked transport system. The uptake of lactate was decreased by alkalization of the extracellular pH, and the K_m values showed a pH dependency [1]. Thus, a dose-dependency study was performed to test the pH-dependent affinity of MCT4 for nicotinic acid (Fig 5B and 5C). MCT4 showed a much lower affinity for nicotinic acid in an alkaline condition than in an acidic condition. The affinities were found to be in the following order: pH 5.5 (0.57 mM) > pH 7.5 (57 mM). Fig 5D shows the effect of lactate as a classical substrate on nicotinic acid uptake via MCT4. Lactate inhibited nicotinic acid uptake in a concentration-dependent manner. This experiment was performed when radiolabeled nicotinic acid and non-labeled lactate were added at the same time to the reaction.

Download:

Fig 4. Effects of various compounds on DEPC modification.

Oocytes were pre-incubated for 10 min in a transport buffer (pH 7.5) containing 2.5 mM DEPC at 25°C in the absence or presence of 100 mM lactate, 100 mM propionic acid, 50 mM nicotinic acid, 20 mM salicylic acid, 10 mM ibuprofen and 5 mM zinc. After treatment with DEPC, the oocytes were rinsed twice with a transport buffer not including a radiolabeled compound. Oocytes were additionally incubated twice for 5 min each time with the transport buffer. The oocytes were incubated for 10 min in a transport buffer of pH 5.5 containing 0.1 mM lactate (0.1 μCi/ml). Data are presented as means±S.E. of three experiments. MCT4-specific uptake was calculated by subtracting the uptake in water-injected oocytes from the uptake in MCT4 cRNA-injected oocytes.

https://doi.org/10.1371/journal.pone.0122738.g004

Download:

Fig 5. Nicotinic acid transport via MCT4.

(A) MCT4 cRNA-injected or water-injected oocytes were incubated for 5 min at 25°C with 10 nM nicotinic acid (0.5 μCi/ml) at pH 5.5 or 7.5. Data are presented as means±S.E. of three experiments. Uptake of nicotinic acid was measured with 5-min incubation at 25°C in a transport buffer of pH 5.5 (B) or pH 7.5 (C) in the presence of an increasing dose of nicotinic acid. The background uptake values of water-injected oocytes were subtracted. Only the MCT4-specific uptake was used for kinetic analysis. Results are Hanes plots for which each value is the mean value for three experiments, and lines were fitted using the least-squares method: from each line, K_m was estimated as the x-axis intercept. (D) Dose dependency of MCT4-mediated lactate inhibition of nicotinic acid uptake. The nicotinic acid uptake was measured at pH 5.5 for 5 min. Data are presented as means±S.E. of three experiments.

https://doi.org/10.1371/journal.pone.0122738.g005

Download:

Table 1. Uptake of nicotinic and salicylic acids in MCT4 and MCT1 cRNA-injected oocytes and water-injected oocytes

https://doi.org/10.1371/journal.pone.0122738.t001

The pH-sensitivity of lactate transport via MCT4 mutant

The complete abolishment of pH dependency of MCT4 by DEPC treatment indicated that a histidine residue plays an important role in the regulation of activity. However, the position of the histidine residue is not known. To address this issue, based on a putative topology model of MCT4 (Fig 6) [1], we mutated the amino acid residue that might be involved in extracellular pH dependency. This protein has five histidine residues, one in the extracellular loop, another in the intracellular loop and the other three in the carboxy terminal facing the cytosol. DEPC cannot react with histidine residues located in the intracellular side within proteins because it is membrane-impermeable [16]. Hence, we considered that the histidine residue located in the extracellular loop is important for the pH dependency. The activity of MCT4-H382A was weak compared with that of the wild type (Fig 7A). These results imply that the sensitivity of the mutant for lactate and/or proton was decrease compared with that of the wild type. We then investigated the kinetic characteristic of lactate transport via MCT4-H382A. The transport of lactate via the mutant was saturated at high concentrations of lactate. The kinetic parameters at pH 5.5 were calculated by nonlinear regression of the Michaelis-Menten equation, and K_m and V_max values were estimated to be 3.3±0.3 mM and 55±1.6 pmol/min/oocyte, respectively (Table 2). The K_m value was similar to a previously reported value for MCT4-WT-expressing oocytes [1]. Fig 7B shows the inhibitory effects of zinc on lactate uptake via MCT4-WT and MCT4-H382A. Zinc inhibited lactate uptake in WT-expressing oocytes, but we could not detect any effect of zinc on lactate uptake in the mutant-expressing oocytes (p>0.05). We then investigated the effects of chemical modification of histidine by DEPC treatment on MCT4-WT and MCT4-H382A-mediated lactate transport (Fig 7C). DEPC treatment greatly suppressed the transport activity of MCT4-WT. However, we could not detect a suppressive effect of DEPC treatment on the transport activity of MCT4-H382A (p>0.05). These results indicated that His382 is a zinc and DEPC-binding site and that this residue plays a crucial role in MCT4 activity. The pH dependency of MCT4-H382A was similar to that of MCT4-WT under the DEPC treatment condition (Fig 7D and Table 3). These observations revealed that the extracellular loop histidine residue His382 located at least near the substrate recognition site contributed markedly to DEPC-sensitive pH regulation of MCT4 function. However, His382 is not a direct substrate binding site because MCT4 activity did not disappear with this mutation.

Download:

Fig 6. Putative topology of human MCT4.

The histidine residues of MCT4 are shown in red.

https://doi.org/10.1371/journal.pone.0122738.g006

Download:

Fig 7. Transport of lactate via MCT4-mutant.

(A) Oocytes injected with MCT4-WT cRNA, MCT4-H382A cRNA, or water were incubated with 0.1 mM lactate (0.1 μCi/ml) for 10 min. (B) Sensitivities against 5 mM zinc of lactate transport activities via MCT4 with a histidine residue mutant. Uptake of 0.1 mM lactate (0.1 μCi/ml) was measured at pH 7.5 for 10 min. (C) Wild-type and histidine mutant MCT4 cRNA-injected oocytes were incubated for 10 min with/without 2.5 mM DEPC in a buffer of pH 7.5 at 25°C. Uptake of 0.1 mM lactate (0.1 μCi/ml) was measured for 10 min at pH 5.5. (D) pH regulation of lactate uptake via wild-type and mutant MCT4. Uptake of 0.1 mM lactate was measured for 10 min at the indicated pH by oocytes expressing proteins of interest. Values are presented as percentages of uptake measured at pH 5.5. All data are presented as means±S.E. of three experiments.

https://doi.org/10.1371/journal.pone.0122738.g007

Download:

Table 2. Kinetic parameters of lactate transport via MCT4.

https://doi.org/10.1371/journal.pone.0122738.t002

Download:

Table 3. pH regulation of wild-type and mutant MCT4 functions.

https://doi.org/10.1371/journal.pone.0122738.t003

Discussion

In this study, we found an MCT4-specific inhibitory effect of zinc at pH 7.5 on lactate transport via MCT4, indicating that the zinc-susceptible residue is one of the functional residues of MCT4. There was no inhibitory effect of zinc in an acidic condition (pH 5.5), suggesting that zinc could not bind to the residue in a protonation state. The pK_a value of this residue is between 5.5 and 7.5. This value accords with pK_a of the histidine residue. Moreover, it is known that the order of the strength of affinity to histidine is copper > nickel > zinc [17–19], in agreement with this experimental result. Under the experimental conditions used in our study, we could not detect any interaction of metal with MCT1. We assumed that the difference is because the histidine residues between MCT1 and MCT4 are not conserved.

Treatment with DEPC, a histidine-modifying reagent, inhibited lactate uptake via MCT4, but ~20% of MCT4 activity was retained. To obtain further evidence for the role of histidine residues, the influence of DEPC on pH dependency of MCT4 function was investigated. The pH regulation of transport activity completely disappeared with DEPC treatment in MCT4-expressing oocytes, suggesting that the DEPC-sensitive histidine residue is an extracellular pH sensor for regulation of MCT4 function. We tried DEPC modification, but MCT1 activity was abolished and investigation of the transport mechanism was therefore impossible.

In the next series of experiments, the effect of DEPC modification in the presence of monocarboxylic acids and zinc was tested. We found that DEPC modification in the presence of lactate as a classical substrate for MCT4 preserved the transport activity, indicating that the important residues of histidine are protected by a substrate excess. We also found that the residue is protected by nicotinic acid but not by propionic acid and monocarboxylate drugs such as salicylic acid and ibuprofen. These results indicate that propionic acid and the drugs may be not substrates for MCT4. In fact, we could not obtain evidence that MCT4 transports these compounds including propionic acid, salicylic acid and ibuprofen. Although both nicotinic acid and lactate were shown to be MCT4 substrates, the effect of nicotinic acid was only half of that of lactate. The reason for this may be that the water solubility and affinity of nicotinic acid are low [20, 21]. Emoto et al. reported that nonsteroidal anti-inflammatory drugs (NSAIDs), such as salicylic acid and ibuprofen, noncompetitively inhibited the uptake of lactate [22]. Therefore, our data lend support to the results of the previous study showing that a lactate transporter does not have an NSAID transport function. However, Hosoya et al. reported that rat lactate transporter-mediated lactate uptake was inhibited by salicylic acid, which competitively inhibited this process [23]. The functions of human MCT isoforms and rat Mct isoforms may be different. The DEPC-induced suppression of lactate uptake via MCT4 was also prevented by zinc. These results indicated that at least one DEPC-sensitive histidine residue located near the substrate binding site is responsible for conferring pH regulation. It is well known that metals are combined with a protein surface. For instance, it has been reported that zinc inhibits proton-dependent glycine transport by glycine transporter subtype 1b [24]. This transporter has histidine residues in the extracellular loops and these residues are zinc-binding sites.

In order to determine whether histidine residues are involved in the regulation of transport activity by pH, we mutated an amino acid residue that might be involved in MCT4-mediated lactate transport. MCT4 has five histidine residues, one in the extracellular loop, another in the intracellular loop and the other three in the carboxy terminal facing the cytosol. It is very unlikely that histidine residues on the intracellular side participate in the pH regulation of transport function. Hence, we analyzed the role of His382 for pH dependency in the function of MCT4. On switching from pH 5.5 to 7.5, pH 7.5/pH 5.5 uptake ratio of MCT4-WT was 0.2 (Table 3). On the other hand, the ratios of MCT4-WT/DEPC and MCT4-H382A were 1.0 and 1.0, respectively. It is known that DEPC cannot react with histidine residues located in the intracellular side within membrane proteins. Therefore, the possibility that histidine residues located in the intracellular side contribute to extracellular pH-dependent lactate uptake via MCT4 is very low. Intracellular pH dependency of MCT4-mediated efflux has not been reported. Histidine residues other than His382 (His350, His430, His445 and His459) might be relevant to intracellular pH-dependent lactate efflux via MCT4. Interaction of between His382 and lactate was not detected, suggesting that His382 is not a substrate binding site because the K_m value for MCT4-mutant was similar to K_m value for MCT4-WT. In addition, Zinc and DEPC did not affect transport in the mutant in which MCT4 activity had been significantly suppressed. Therefore, it is thought that the histidine residue is not a part of the substrate binding pocket and, as a consequence, the most probable histidine residue seems to be the proton coupling site, His382. We have already reported that Arg278 is involved in lactate recognition by MCT4 [1]. Hence, Arg278 and His382 in the structure of MCT4 probably exist at nearby locations. We also examined the potential interaction of a proton with this residue. It is known that histidine residues are involved in binding and movement of protons by other carriers [11, 25, 26] and may operate as a pH sensor [27]. The pH regulation of MCT4-H382A function was knocked out completely. It seems that this residue is involved in binding and movement of a proton (Fig 8).

Download:

Fig 8. His382 is extracellular pH sensor.

Taken together, our findings demonstrate that the non-conserved residue His382 in the extracellular loop of MCT4 is essential for pH regulation of MCT4-mediated lactate transport activity. The results of this study should be useful for development of a drug delivery system using MCT4.

https://doi.org/10.1371/journal.pone.0122738.g008

Author Contributions

Conceived and designed the experiments: SS. Performed the experiments: SS. Analyzed the data: SS MK. Contributed reagents/materials/analysis tools: SS YF. Wrote the paper: SS MK YF JO HY KI.

References

1. Sasaki S, Kobayashi M, Futagi Y, Ogura J, Yamaguchi H, Takahashi N, et al. Crucial residue involved in L-lactate recognition by human monocarboxylate transporter 4 (hMCT4). PLoS ONE. 2013; 8; e67690. pmid:23935841
- View Article
- PubMed/NCBI
- Google Scholar
2. Lin RY, Vera JC, Chaganti RSK, Golde DW. Human monocarboxylate transporter 2 (MCT2) is a high affinity pyruvate transporter. J Biol Chem. 1998; 273; 28959–28965. pmid:9786900
- View Article
- PubMed/NCBI
- Google Scholar
3. Miyauchi S, Gopal E, Fei YJ, Ganapathy V. Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na⁺-coupled transporter for short-chain fatty acids. J Biol Chem. 2004; 279; 13293–13296. pmid:14966140
- View Article
- PubMed/NCBI
- Google Scholar
4. Plata C, Sussman CR, Sind̄ić A, Liang JO, Mount DB, Josephs ZM, et al. Zebrafish Slc5a12 encodes an electroneutral sodium monocarboxylate transporter (SMCTn). J Biol Chem. 2007; 282; 11996–12009. pmid:17255103
- View Article
- PubMed/NCBI
- Google Scholar
5. Thwaites DT, Anderson CMH. H⁺-coupled nutrient, micronutrient and drug transporters in the mammalian small intestine. Exp Physiol. 2005; 92; 603–619.
- View Article
- Google Scholar
6. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 1997; 388; 482–488. pmid:9242408
- View Article
- PubMed/NCBI
- Google Scholar
7. Lam-Yuk-Tseung S, Govoni G, Forbes J, Gros P. Iron transport by Nramp2/DMT1: pH regulation of transport by 2 histidines in transmembrane domain 6. Blood. 2003; 101; 3699–3707. pmid:12522007
- View Article
- PubMed/NCBI
- Google Scholar
8. Qiu A, Jansen M, Sakaris A, Min SH, Chattopadhyay S, Tsai E, et al. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell. 2006; 127; 917–928. pmid:17129779
- View Article
- PubMed/NCBI
- Google Scholar
9. Unal ES, Zhao R, Chang MH, Fiser A, Romero MF, Goldman ID. The functional roles of the His247 and His281 residues in folate and proton translocation mediated by the human proton-coupled folate transporter SLC46A1. J Biol Chem. 2009; 284; 17846–17857. pmid:19389703
- View Article
- PubMed/NCBI
- Google Scholar
10. Fei YJ, Kanai Y, Nussberger S, Ganapathy V, Leibach FH, Romero MF, et al. Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature. 1994; 368; 563–566. pmid:8139693
- View Article
- PubMed/NCBI
- Google Scholar
11. Fujisawa Y, Tateoka R, Nara T, Kamo N, Taira T, Miyauchi S. The extracellular pH dependency of transport activity by human oligopeptide transporter 1 (hPEPT1) expressed stably in Chinese hamster ovary (CHO) cells: a reason for the bell-shaped activity versus pH. Biol Pharm Bull. 2006; 29; 997–1005. pmid:16651734
- View Article
- PubMed/NCBI
- Google Scholar
12. Metzner L, Brandsch M. Influence of a proton gradient on the transport kinetics of the H+/amino acid cotransporter PAT1 in Caco-2 cells. Eur J Pharm Biopharm. 2006; 63; 360–364. pmid:16531028
- View Article
- PubMed/NCBI
- Google Scholar
13. Boll M, Foltz M, Rubio-Aliaga I, Daniel H. A cluster of proton/amino acid transporter genes in the human and mouse genomes. Genomics. 2003; 82; 47–56. pmid:12809675
- View Article
- PubMed/NCBI
- Google Scholar
14. Sasaki S, Futagi Y, Kobayashi M, Ogura J, Iseki K. Functional characterization of 5-oxoproline transport via SLC16A1/MCT1. J Biol Chem. 2015; 290; 2303–2311. pmid:25371203
- View Article
- PubMed/NCBI
- Google Scholar
15. Baird FE, Pinilla-Tenas JJ, Ogilvie WL, Ganapathy V, Hundal HS, Taylor PM. Evidence for allosteric regulation of pH-sensitive System A (SNAT2) and System N (SNAT5) amino acid transporter activity involving a conserved histidine residue. Biochem J. 2006; 397; 369–375. pmid:16629640
- View Article
- PubMed/NCBI
- Google Scholar
16. Miles EW. Modification of histidyl residues in proteins by diethylpyrocarbonate. Methods Enzymol. 1977; 47; 431–442. pmid:22021
- View Article
- PubMed/NCBI
- Google Scholar
17. Clemmitt RH, Chase HA. Facilitated downstream processing of a histidine-tagged protein from unclarified E. coli homogenates using immobilized metal affinity expanded-bed adsorption. Biotechnol Bioeng. 2000; 67; 206–216. pmid:10592518
- View Article
- PubMed/NCBI
- Google Scholar
18. Sloane RP, Ward JM, O'Brien SM, Thomas OR, Dunnill P. Expression and purification of a recombinant metal-binding T4 lysozyme fusion protein. J Biotechnol. 1996; 49; 231–238. pmid:8879173
- View Article
- PubMed/NCBI
- Google Scholar
19. Hemdan ES, Zhao YJ, Sulkowski E, Porath J. Surface topography of histidine residues: a facile probe by immobilized metal ion affinity chromatography. Proc Natl Acad Sci U S A. 1989; 86; 1811–1815. pmid:2538816
- View Article
- PubMed/NCBI
- Google Scholar
20. Tachikawa M, Murakami K, Martin PM, Hosoya K, Ganapathy V. Retinal transfer of nicotinate by H+-monocarboxylate transporter at the inner blood-retinal barrier. Microvasc Res. 2011; 82; 385–390. pmid:21741392
- View Article
- PubMed/NCBI
- Google Scholar
21. Shimada A, Nakagawa Y, Morishige H, Yamamoto A, Fujita T. Functional characteristics of H⁺-dependent nicotinate transport in primary cultures of astrocytes from rat cerebral cortex. Neurosci Lett. 2006; 392; 207–212. pmid:16213084
- View Article
- PubMed/NCBI
- Google Scholar
22. Emoto A, Ushigome F, Koyabu N, Kajiya H, Okabe K, Satoh S, et al. H⁺-linked transport of salicylic acid, an NSAID, in the human trophoblast cell line BeWo. Am J Physiol Cell Physiol. 2002; 282; C1064–1075. pmid:11940522
- View Article
- PubMed/NCBI
- Google Scholar
23. Hosoya K, Kondo T, Tomi M, Takanaga H, Ohtsuki S, Terasaki T. MCT1-mediated transport of L-lactic acid at the inner blood-retinal barrier: a possible route for delivery of monocarboxylic acid drugs to the retina. Pharm Res. 2001; 18; 1669–1676. pmid:11785685
- View Article
- PubMed/NCBI
- Google Scholar
24. Ju P, Aubrey KR, Vandenberg RJ. Zn²⁺ inhibits glycine transport by glycine transporter subtype 1b. J Biol Chem. 2004; 279; 22983–22991. pmid:15031290
- View Article
- PubMed/NCBI
- Google Scholar
25. Fei YJ, Liu W, Prasad PD, Kekuda R, Oblak TG, Ganapathy V, et al. Identification of the histidyl residue obligatory for the catalytic activity of the human H+/peptide cotransporters PEPT1 and PEPT2. Biochemistry. 1997; 36; 452–460. pmid:9003198
- View Article
- PubMed/NCBI
- Google Scholar
26. Metzner L, Natho K, Zebisch K, Dorn M, Bosse-Doenecke E, Ganapathy V, et al. Mutational analysis of histidine residues in the human proton-coupled amino acid transporter PAT1. Biochim Biophys Acta. 2008; 1778; 1042–1050. pmid:18230330
- View Article
- PubMed/NCBI
- Google Scholar
27. Zong X, Stieber J, Ludwig A, Hofmann F, Biel M. A single histidine residue determines the pH sensitivity of the pacemaker channel HCN2. J Biol Chem. 2001; 276; 6313–6319. pmid:11096117
- View Article
- PubMed/NCBI
- Google Scholar

[ref1] 1. Sasaki S, Kobayashi M, Futagi Y, Ogura J, Yamaguchi H, Takahashi N, et al. Crucial residue involved in L-lactate recognition by human monocarboxylate transporter 4 (hMCT4). PLoS ONE. 2013; 8; e67690. pmid:23935841
View Article
PubMed/NCBI
Google Scholar

[2] View Article

[3] PubMed/NCBI

[4] Google Scholar

[ref2] 2. Lin RY, Vera JC, Chaganti RSK, Golde DW. Human monocarboxylate transporter 2 (MCT2) is a high affinity pyruvate transporter. J Biol Chem. 1998; 273; 28959–28965. pmid:9786900
View Article
PubMed/NCBI
Google Scholar

[6] View Article

[7] PubMed/NCBI

[8] Google Scholar

[ref3] 3. Miyauchi S, Gopal E, Fei YJ, Ganapathy V. Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na⁺-coupled transporter for short-chain fatty acids. J Biol Chem. 2004; 279; 13293–13296. pmid:14966140
View Article
PubMed/NCBI
Google Scholar

[10] View Article

[11] PubMed/NCBI

[12] Google Scholar

[ref4] 4. Plata C, Sussman CR, Sind̄ić A, Liang JO, Mount DB, Josephs ZM, et al. Zebrafish Slc5a12 encodes an electroneutral sodium monocarboxylate transporter (SMCTn). J Biol Chem. 2007; 282; 11996–12009. pmid:17255103
View Article
PubMed/NCBI
Google Scholar

[14] View Article

[15] PubMed/NCBI

[16] Google Scholar

[ref5] 5. Thwaites DT, Anderson CMH. H⁺-coupled nutrient, micronutrient and drug transporters in the mammalian small intestine. Exp Physiol. 2005; 92; 603–619.
View Article
Google Scholar

[18] View Article

[19] Google Scholar

[ref6] 6. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 1997; 388; 482–488. pmid:9242408
View Article
PubMed/NCBI
Google Scholar

[21] View Article

[22] PubMed/NCBI

[23] Google Scholar

[ref7] 7. Lam-Yuk-Tseung S, Govoni G, Forbes J, Gros P. Iron transport by Nramp2/DMT1: pH regulation of transport by 2 histidines in transmembrane domain 6. Blood. 2003; 101; 3699–3707. pmid:12522007
View Article
PubMed/NCBI
Google Scholar

[25] View Article

[26] PubMed/NCBI

[27] Google Scholar

[ref8] 8. Qiu A, Jansen M, Sakaris A, Min SH, Chattopadhyay S, Tsai E, et al. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell. 2006; 127; 917–928. pmid:17129779
View Article
PubMed/NCBI
Google Scholar

[29] View Article

[30] PubMed/NCBI

[31] Google Scholar

[ref9] 9. Unal ES, Zhao R, Chang MH, Fiser A, Romero MF, Goldman ID. The functional roles of the His247 and His281 residues in folate and proton translocation mediated by the human proton-coupled folate transporter SLC46A1. J Biol Chem. 2009; 284; 17846–17857. pmid:19389703
View Article
PubMed/NCBI
Google Scholar

[33] View Article

[34] PubMed/NCBI

[35] Google Scholar

[ref10] 10. Fei YJ, Kanai Y, Nussberger S, Ganapathy V, Leibach FH, Romero MF, et al. Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature. 1994; 368; 563–566. pmid:8139693
View Article
PubMed/NCBI
Google Scholar

[37] View Article

[38] PubMed/NCBI

[39] Google Scholar

[ref11] 11. Fujisawa Y, Tateoka R, Nara T, Kamo N, Taira T, Miyauchi S. The extracellular pH dependency of transport activity by human oligopeptide transporter 1 (hPEPT1) expressed stably in Chinese hamster ovary (CHO) cells: a reason for the bell-shaped activity versus pH. Biol Pharm Bull. 2006; 29; 997–1005. pmid:16651734
View Article
PubMed/NCBI
Google Scholar

[41] View Article

[42] PubMed/NCBI

[43] Google Scholar

[ref12] 12. Metzner L, Brandsch M. Influence of a proton gradient on the transport kinetics of the H+/amino acid cotransporter PAT1 in Caco-2 cells. Eur J Pharm Biopharm. 2006; 63; 360–364. pmid:16531028
View Article
PubMed/NCBI
Google Scholar

[45] View Article

[46] PubMed/NCBI

[47] Google Scholar

[ref13] 13. Boll M, Foltz M, Rubio-Aliaga I, Daniel H. A cluster of proton/amino acid transporter genes in the human and mouse genomes. Genomics. 2003; 82; 47–56. pmid:12809675
View Article
PubMed/NCBI
Google Scholar

[49] View Article

[50] PubMed/NCBI

[51] Google Scholar

[ref14] 14. Sasaki S, Futagi Y, Kobayashi M, Ogura J, Iseki K. Functional characterization of 5-oxoproline transport via SLC16A1/MCT1. J Biol Chem. 2015; 290; 2303–2311. pmid:25371203
View Article
PubMed/NCBI
Google Scholar

[53] View Article

[54] PubMed/NCBI

[55] Google Scholar

[ref15] 15. Baird FE, Pinilla-Tenas JJ, Ogilvie WL, Ganapathy V, Hundal HS, Taylor PM. Evidence for allosteric regulation of pH-sensitive System A (SNAT2) and System N (SNAT5) amino acid transporter activity involving a conserved histidine residue. Biochem J. 2006; 397; 369–375. pmid:16629640
View Article
PubMed/NCBI
Google Scholar

[57] View Article

[58] PubMed/NCBI

[59] Google Scholar

[ref16] 16. Miles EW. Modification of histidyl residues in proteins by diethylpyrocarbonate. Methods Enzymol. 1977; 47; 431–442. pmid:22021
View Article
PubMed/NCBI
Google Scholar

[61] View Article

[62] PubMed/NCBI

[63] Google Scholar

[ref17] 17. Clemmitt RH, Chase HA. Facilitated downstream processing of a histidine-tagged protein from unclarified E. coli homogenates using immobilized metal affinity expanded-bed adsorption. Biotechnol Bioeng. 2000; 67; 206–216. pmid:10592518
View Article
PubMed/NCBI
Google Scholar

[65] View Article

[66] PubMed/NCBI

[67] Google Scholar

[ref18] 18. Sloane RP, Ward JM, O'Brien SM, Thomas OR, Dunnill P. Expression and purification of a recombinant metal-binding T4 lysozyme fusion protein. J Biotechnol. 1996; 49; 231–238. pmid:8879173
View Article
PubMed/NCBI
Google Scholar

[69] View Article

[70] PubMed/NCBI

[71] Google Scholar

[ref19] 19. Hemdan ES, Zhao YJ, Sulkowski E, Porath J. Surface topography of histidine residues: a facile probe by immobilized metal ion affinity chromatography. Proc Natl Acad Sci U S A. 1989; 86; 1811–1815. pmid:2538816
View Article
PubMed/NCBI
Google Scholar

[73] View Article

[74] PubMed/NCBI

[75] Google Scholar

[ref20] 20. Tachikawa M, Murakami K, Martin PM, Hosoya K, Ganapathy V. Retinal transfer of nicotinate by H+-monocarboxylate transporter at the inner blood-retinal barrier. Microvasc Res. 2011; 82; 385–390. pmid:21741392
View Article
PubMed/NCBI
Google Scholar

[77] View Article

[78] PubMed/NCBI

[79] Google Scholar

[ref21] 21. Shimada A, Nakagawa Y, Morishige H, Yamamoto A, Fujita T. Functional characteristics of H⁺-dependent nicotinate transport in primary cultures of astrocytes from rat cerebral cortex. Neurosci Lett. 2006; 392; 207–212. pmid:16213084
View Article
PubMed/NCBI
Google Scholar

[81] View Article

[82] PubMed/NCBI

[83] Google Scholar

[ref22] 22. Emoto A, Ushigome F, Koyabu N, Kajiya H, Okabe K, Satoh S, et al. H⁺-linked transport of salicylic acid, an NSAID, in the human trophoblast cell line BeWo. Am J Physiol Cell Physiol. 2002; 282; C1064–1075. pmid:11940522
View Article
PubMed/NCBI
Google Scholar

[85] View Article

[86] PubMed/NCBI

[87] Google Scholar

[ref23] 23. Hosoya K, Kondo T, Tomi M, Takanaga H, Ohtsuki S, Terasaki T. MCT1-mediated transport of L-lactic acid at the inner blood-retinal barrier: a possible route for delivery of monocarboxylic acid drugs to the retina. Pharm Res. 2001; 18; 1669–1676. pmid:11785685
View Article
PubMed/NCBI
Google Scholar

[89] View Article

[90] PubMed/NCBI

[91] Google Scholar

[ref24] 24. Ju P, Aubrey KR, Vandenberg RJ. Zn²⁺ inhibits glycine transport by glycine transporter subtype 1b. J Biol Chem. 2004; 279; 22983–22991. pmid:15031290
View Article
PubMed/NCBI
Google Scholar

[93] View Article

[94] PubMed/NCBI

[95] Google Scholar

[ref25] 25. Fei YJ, Liu W, Prasad PD, Kekuda R, Oblak TG, Ganapathy V, et al. Identification of the histidyl residue obligatory for the catalytic activity of the human H+/peptide cotransporters PEPT1 and PEPT2. Biochemistry. 1997; 36; 452–460. pmid:9003198
View Article
PubMed/NCBI
Google Scholar

[97] View Article

[98] PubMed/NCBI

[99] Google Scholar

[ref26] 26. Metzner L, Natho K, Zebisch K, Dorn M, Bosse-Doenecke E, Ganapathy V, et al. Mutational analysis of histidine residues in the human proton-coupled amino acid transporter PAT1. Biochim Biophys Acta. 2008; 1778; 1042–1050. pmid:18230330
View Article
PubMed/NCBI
Google Scholar

[101] View Article

[102] PubMed/NCBI

[103] Google Scholar

[ref27] 27. Zong X, Stieber J, Ludwig A, Hofmann F, Biel M. A single histidine residue determines the pH sensitivity of the pacemaker channel HCN2. J Biol Chem. 2001; 276; 6313–6319. pmid:11096117
View Article
PubMed/NCBI
Google Scholar

[105] View Article

[106] PubMed/NCBI

[107] Google Scholar

Figures

Abstract

Introduction

Methods

Synthesis of cRNA

Site-directed mutagenesis

Uptake measurements in MCT1 cRNA or MCT4 cRNA-injected oocytes

Materials

Results

Effects of metals on transport activity of MCT4

Effect of a histidine residue modifier, DEPC, on lactate transport through MCT4-expressing oocytes

Effects of monocarboxylates on the DEPC modification of MCT4

The pH-sensitivity of lactate transport via MCT4 mutant

Discussion

Author Contributions

References